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Abstract
Schistosomiasis affects approximately 240 million people in the world. Schistosoma man-
soni eggs in the liver induce periportal fibrosis and hepatic failure driven by monocyte
recruitment and macrophage activation, resulting in robust Th2 response. Here, we sug-
gested a possible involvement of Galectin-3 (Gal-3), histone deacetylases (HDACs), and
Hedgehog (Hh) signaling with macrophage activation during Th1/Th2 immune responses,
fibrogranuloma reaction, and tissue repair during schistosomiasis. Gal-3 is highly expressed
by liver macrophages (Kupffer cells) around Schistosoma eggs. HDACs and Hh regulate
macrophage polarization and hepatic stellate cell activation during schistosomiasis-associ-
ated fibrogenesis. Previously, we demonstrated an abnormal extracellular matrix distribution
in the liver that correlated with atypical monocyte–macrophage differentiation in S. mansoni-
infected, Gal-3-deficient (Lgals3-/-) mice. New findings explored in this review focus on the
chronic phase, when wild-type (Lgals3+/+) and Lgals3-/- mice were analyzed 90 days after
cercariae infection. In Lgals3-/- infected mice, there was significant inflammatory infiltration
with myeloid cells associated with egg destruction (hematoxylin and eosin staining), phago-
cytes (specifically Kupffer cells), numerically reduced and diffuse matrix extracellular depo-
sition in fibrotic areas (Gomori trichrome staining), and severe disorganization of collagen
fibers surrounding the S. mansoni eggs (reticulin staining). Granuloma-derived stromal cells
(GR cells) of Lgals3-/- infected mice expressed lower levels of alpha smooth muscle actin
(α-SMA) and eotaxin and higher levels of IL-4 than Lgals3+/+ mice (real-time PCR). The rel-
evant participation of macrophages in these events led us to suggest distinct mechanisms
of activation that culminate in defective fibrosis in the liver of Lgals3-/- infected mice. These
aspects were discussed in this review, as well as the possible interference between Gal-3,
HDACs, and Hh signaling during progressive liver fibrosis in S. mansoni-infected mice.
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Further studies focused on macrophage roles could elucidate these questions and clear the
potential utility of these molecules as antifibrotic targets.
Schistosomiasis and the establishment of liver fibrosis
Parasitic infections are one of the most common causes of liver diseases in humans [1]. Hel-
minthes of the genus Schistosoma cause a neglected tropical disease that affects approximately
240 million people, mainly in developing countries. The three major schistosomes infecting
humans are S. mansoni, S. japonicum, and S. haematobium. S. mansoni is most commonly
found in the endemic areas of Africa and Latin America and is a major public health concern
because it often infects people who are likely to swim in fresh water containing snails that har-
bor sporocysts and release cercariae (the larval infective form of the parasite [2]) in the water.
S. mansoni infection leads to periportal fibrosis, portal hypertension, ascites, and gastrointesti-
nal bleeding correlated with bloody diarrhea, abdominal pain, right upper quadrant pain, and
esophageal varices, resulting in severe symptoms and death in approximately 60% of infected
patients [3,4]. Although the World Health Organization introduced regulations to control the
growth of schistosomiasis, its prevalence is significantly high in some countries, including Bra-
zil and China [5,6].
Schistosomiasis mansoni leads to liver diseases because of egg deposition in the periportal
zones, which induces a granulomatous reaction that culminates in liver fibrosis and portal
hypertension [7]. The prehepatic phase is preceded by cercarial penetration through the skin
with significant changes in the epidermis [8]. After skin penetration, the infecting form trans-
forms into schistosomules that reach the lungs and later accumulate in the hepatic portal sys-
tem as adult worms, where they release large numbers of eggs [9]. Some of these eggs cause
abscesses in the intestinal wall, some are expelled into intestinal lumen, and the remaining
eggs are washed through the portal blood flow into the liver. After reaching the intrahepatic
portal system, they bring about a switch from an exudative to a progressive fibrogranuloma-
tous inflammatory reaction [10,11,12].
At the beginning of the eggs’ deposition, their antigens induce a local production of inflam-
matory cytokines (IL-1 and TNF-α) from resident epithelial cells and macrophages that trigger
the early influx of monocytes and neutrophils, forming a macrophage-dependent granulomatous
inflammatory reaction [13,14,15,16]. At the systemic level, there is a moderate Th1 response
against schistosomula-maturing worms antigens that is crucial to mobilize blood monocytes
from bone marrow towards the eggs trapped into the mesenteric venous system [10]. It has
been shown in the literature that blood monocytes are a heterogeneous population based primar-
ily on the amount of time they spend in the blood before migrating into tissues [17,18]. For
instance, it has been described that proinflammatory (Ly6ClowCD11b+CCR2+CX3CR1−F4/
80+CD62L−CD43) and profibrotic monocyte (Ly6ChighCD11b+CCR2−CX3CR1+F4/80+CD43−)
phenotypes may be modulated, regulating the initiation, maintenance, and resolution of chronic
inflammatory response [17,18]. Thus, the macrophages play a critical role at the beginning of
exudative granulomas formation, modulating the behavior of resident epithelial cells and quies-
cent hepatic stellate cells [19]. In contrast to Th1 response caused by worms antigens, the eggs
antigens evoke a strong Th2 response that maintains the vigorous exudative granulomas until 8
weeks post-cercariae penetration [10,20,21,22], when the acute phase is downregulated and then
replaced by a persistent chronic phase. During this transitory phase, the continuous egg deposi-
tion in the intrahepatic mesenteric system did not compromise the liver parenchyma. This bar-
rier is ensured mainly by macrophages that switch from protective role at the acute phase to a
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wound-healing pattern, driving a concentric fibrotic reaction, which is a hallmark of the chronic
phase [23]. In addition, we also noticed the following during the chronic phase: hepatosplenome-
galy, polyclonal B cell activation, extra medullar hematopoiesis, and peritoneal macrophage
hyperactivity [24].
Gal-3 binds to Schistosoma and egg antigens and promotes liver
fibrosis: A central role of macrophages
Gal-3 is a β-galactoside binding protein that regulates cellular activation, migration, survival,
and immune response in distinct experimental models [25,26,27]. Hsu et al. (1999) showed
that Gal-3 expression was absent in normal hepatocytes but was abundant in hepatocellular
carcinoma, and its inhibition in these malignant cells reduced the attachment to laminin and
liver metastasis [28]. Lee et al. (2002) suggested that both IL-10 and Gal-3 could cooperatively
protect liver cells from ischemia reperfusion injury, controlling NO production as well as pro-
tecting the cell from injury [29]. In humans, Gal-3 is significantly accumulated in cirrhotic liv-
ers, and high levels of the serum are associated with alcoholic liver diseases [28], suggesting a
direct correlation with the fibrotic stage.
In the experimental model of hepatic injury, Gal-3 has been shown to regulate the induc-
tion and resolution of hepatic fibrosis. Using Lgals3-/- mice, the data suggests that Gal-3 is
required for TGF-beta-mediated myofibroblast activation and matrix production [30]. In this
context, the inflammatory process involved an acute hepatocytes lesion induced by carbon tet-
rachloride (CCl4). In this sense, the hepatic fibrosis is installed in a short period of time com-
pared with the long-lasting chronic inflammatory process.
Gal-3 has also been shown to induce an immune response against S. mansoni; this lectin is
one of the major ligands of the polylactosamines, including GalNAc_1-4(Fuc_1–3)GlcNAc
(Lac-DiNAc) structures (N-acetylgalactosamine _1–4 N-acetylglucosamine) synthesized by the
worms and their eggs. As Gal-3 is highly expressed in inflammatory cells surrounding liver
granulomas, it could be considered a pathogen-associated molecular pattern receptor, favoring
an interactive network between macrophages and immunogenic carbohydrates [31].
In long-lasting inflammatory reactions using Lgals3-/- mice, it has been shown that macro-
phage share is not properly differentiated in liver granulomas and in lymphoid organs involved
with the disease, such as mesenteric lymph nodes and spleen [32,33,34]. Indeed, the absence of
Gal-3 also interfered with the function of Kupffer cells, the resident liver macrophages. They
have a high capacity to phagocyte the secreta and excreta of the worms, becoming pigmented
cells and secreting mainly IL-4 and IL-13 during the infection [11,35].
Although we have not used specific cell markers to identify these phagocytic cells, we
observed that pigmented macrophages were abundant around the eggs in Lgals3+/+-infected
mice, but were rarely found in livers of Lgals3-/- mice (Fig 1). Although we have not investi-
gated if Gal-3 directly affects Kupffer cell numbers or phagocytic functions, these data demon-
strate the correlation between matrix composition and Gal-3 expression. Future studies will be
necessary to elucidate if and how Gal-3 modulates monocyte–macrophage functions in Schis-
tosomiasis-associated liver fibrogenesis.
Concomitantly with this low phagocytic capacity of Kupffer cells in Lgals3-/- infected mice,
there is a systemic delay in monocyte–macrophage differentiation in the periovular fibrogra-
nulomatous reaction [32]. It drastically affects the granuloma organization, which is character-
ized by thinner collagen fibers abnormally diffuse throughout the liver parenchyma. Indeed,
we confirmed that in the absence of Gal-3, the extracellular matrix deposition was widely dis-
persed throughout the liver parenchyma and loosely concentric around the egg deposition
(Fig 2). These data strongly suggest that Gal-3-dependent macrophage activation could
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interfere with the outcome of the inflammatory process, modifying the pattern of extracellular
matrix deposition by the hepatic stellate cell (HSC), maintaining, at least in part, the hepato-
cyte integrity. Thus, altogether, these data reinforce the role of Gal-3 in macrophage phagocy-
tosis, described firstly by Sano et al., placing these cells as central players in both innate and
adaptive immunity and modulating early and late stages of the inflammatory process [36].
Gal-3 and hepatic stellate cells activation
In addition to the role of macrophages in granulomatous reaction, there is a relevant function
for HSCs characterized by an excessive and continuous extracellular matrix deposition leading
to liver injury. As a result, the HSCs change from the quiescent to an activated myofibroblastic
phenotype and should be considered primary targets for the development of new antifibrotic
therapies [37,38]
In fact, Gal-3 has been also shown to play a key role in liver fibrosis by mediating HSC acti-
vation and procollagen expression [30,38]. HSCs derived from chronic granulomas of S.
mansoni-infected mice (GR-HSC) have been previously characterized by our group as myofi-
broblast cells with an important role during granulomatous reaction. As immunoregulatory
cells, they produce proinflammatory cytokines that amplify the local response against the eggs
antigens, contributing significantly to the pathogenesis of schistosomiasis [37,39].
In addition, we observed that GR-HSCs of Lgals3-/- mice expressed reduced levels of α-
SMA compared to those isolated from granulomas of Lgals3+/+ infected mice (Fig 2E and 2F).
In accordance, Jiang et al. (2012) demonstrated that HSCs from Lgals3-/- mice displayed
Fig 1. Local Kupffer cells show a decreased phagocytic activity in S. mansoni-infected Lgals3-/- mice.
Classical pigmented Kupffer cells were not observed around granulomas from Lgals3-/- mice (B,D) in contrast
to a high phagocytic activity found in Lgals3+/+ mice (A,C). A-B: Hematoxylin & eosin staining. C-D: Gomori
trichrome staining. Magnification: 400x. n = 5 mice per group.
doi:10.1371/journal.pntd.0005137.g001
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Fig 2. Gal-3 is necessary for fibrotic concentric granulomas in S. mansoni infected mice and
myofibroblast activation. Hematoxylin & eosin and Gomori trichrome staining show classical concentric
fibrotic granulomas of Lgals3+/+ (A,C dashed line) and more diffuse and dispersed collagen fibers around the
S. mansoni eggs of Lgals3-/- mice (B,D dashed line). Real-time reverse transcription PCR (RT-PCR) to alpha
smooth muscle actin (E) and IL-4 (F) expressed by granuloma-hepatic stellate cells (GR-HSCs) from Lgals3+/+
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reduced phagocytic activity and reduced expression of α-SMA and procollagen α1. The
authors have shown that the extracellular Gal-3 has a key role in liver fibrosis, interfering
directly with HSC function [38]. The lower levels of α-SMA expression by HSCs in the absence
of Gal-3 indicate that Gal-3 positively regulates profibrotic events in the liver. On the other
hand, histological analysis revealed that a diffuse patter of collagen fibers and fibrotic areas
were spatially increased in these knockout mice, suggesting a more extensive region with extra-
cellular matrix deposition in the liver of Lgals3-/- infected mice in comparison with Lgals3
+/+ infected mice. In this context, we can suggest that, in the absence of macrophages activa-
tion, the GR-HSCs are less activated and, consequently, less synthetic.
Our data suggest that a high expression of IL-4 in isolated GR-HSCs from Lgals3-/- rein-
forces the immunomodulatory role of these cells, interfering with Th1/Th2 balance during the
chronic phase of infection (Fig 2F). In accordance, IL-4αR-/- mice (nonresponsive to both IL-
4 and IL-13) developed only minimal hepatic granulomas and fibrosis [40], confirming that
both cytokines are critical to induce the Th2 response in schistosomiasis [14].
Another hallmark of experimental murine schistosomiasis raised by our studies is a signifi-
cant inflammatory infiltrate on periovular granulomas in the chronic phase (Fig 3A and 3B).
In contrast to Lgals3+/+ mice, in which mononuclear cells were predominantly observed sur-
rounding the eggs (Fig 3C and 3E), in Lgals3-/- mice, we observed that polymorphonuclear
leucocytes were the predominant cells, organized in well-defined niches or clusters (Fig 3D).
This scenario suggests a peripheral amplification in response (at least in part) to local cytokines
and to stromal supportive GR-HSCs. It is interesting to point out the presence of myeloid pro-
genitor cells in contact with the hepatocytes, indicating a spreading of these cells out of the
periovular granulomas in Lgals3-/- mice (Fig 3D and 3F).
Another interesting finding of our studies concerning the composition of inflammatory
cells around the egg granulomas in Lgals3-/- mice was the predominance of eosinophils in
liver granulomas compared with Lgals3+/+ mice [32]. The GR-HSCs of both groups of mice
expressed similar levels of IL-5, the critical cytokines for differentiation and proliferation of
eosinophils [41]. In contrast, eotaxin, a main chemoatractant chemokine for eosinophils [42],
was significantly downregulated in GR-HSCs in the absence of Gal-3 (Fig 3H). In this context,
we can suggest that in the absence of Gal-3, the low expression of eotaxin in GR-HSCs, even
without alteration in IL-5 expression, favored the local proliferation of myeloid cells instead of
the mobilization from bone marrow (Fig 4).
Hh signaling regulates liver fibrosis during schistosomiasis
Recently, the Hh signaling pathway has been extensively investigated as a possible mediator of
chronic liver inflammation and fibrosis. The Hh pathway normally plays a critical role in
embryonic development and organogenesis, but in the adult, it has been shown to promote
cancer development and progression [43,44,45]. In the normal adult liver, Hh signaling is
switched off but could be reactivated during liver injury in HSCs, hepatocytes, and macro-
phages and, if activity is unchecked, may lead to liver fibrosis and cirrhosis [46,47,48]. Hh
ligands can also stimulate liver progenitor cells to proliferate and secrete profibrogenic factors
such as osteopontin (a matrix molecule and cytokine) and chemokines such as CXCL16 or
MCP-1 that chemoattract immune cells that amplify the fibrogenic response. Conversely,
and Lgals3-/- mice shows the imbalance between extracellular matrix production and proinflammatory
cytokines. The relative value was obtained in relation to the Hypoxanthine Guanine Phosphoribosyl
Transferase (HPRT) expression. Each bar represents the mean ±SEM, n = 5. These graphs are representative
of three experiments. *P0.05 compared with Lgals3+/+ mice. Magnification: 400x. n = 5 mice per group.
doi:10.1371/journal.pntd.0005137.g002
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Fig 3. Inflammatory infiltrate is amplified in the absence of Gal-3 in S. mansoni-infected mice.
Hematoxylin & eosin staining show granulomas of Lgals-3+/+ mice (A) and Lgals-3-/- mice (B), where
abundant myeloid cells were detected around the eggs. Myeloid cells were preferentially localized around the
eggs in Lgals-3+/+ mice (C,E). In contrast, myeloid cells were abundant around the eggs and inside the
hepatic parenchyma in Lgals-3-/- mice (D,F), suggesting a local amplification instead of central mobilization.
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inhibiting the Hh pathway significantly attenuates fibrotic outcomes [49,50], confirming the
Hh pathway as a target to control liver fibrosis.
Patients with Schistosomiasis-associated portal fibrosis and portal hypertension express
high levels of Hh activity in situ [47]. Specifically, the degree of Hh pathway activation
Hematoxylin & eosin staining. Real-time RT-PCR to IL-5 (G) and Eotaxin (H) expressed by GR-HSCs from
Lgals-3+/+ and Lgals-3-/- mice reinforce the hypothesis of local myeloid amplification. The relative value was
obtained in relation to HPRT expression. Each bar represents the mean ±SEM, n = 5. These graphs are
representative of three experiments. *P0.05 compared with Lgals3+/+ mice. Magnification: A-B: 100x; C-F:
1,000x. n = 5 mice per group.
doi:10.1371/journal.pntd.0005137.g003
Fig 4. Schematic illustration of different stages of schistosomiasis and opening questions in the field. (A) Schematic illustrating
liver histological architecture upon schistosomiasis infection in Lgals3+/+ and Lgals3-/- mice. Schistosomules accumulate in the hepatic
portal system. Monocytes are recruited by eggs and worms antigens, becoming the central players during the first steps of the establishment
of the disease. Macrophages trigger bone marrow mobilization and myofibroblast activation that, in turn, bring hepatocytes into the
inflammatory process. By contrast, in Schistosoma-infected Lgals3-/- mice, macrophages are not properly activated, suggesting
disturbances in monocyte recruitment, Sonic hedgehog (Shh) secretion, HDAC activity, and extracellular matrix deposition by myofibroblast
cells. (B) Suggestion of possible mechanisms to be investigated in the near future.
doi:10.1371/journal.pntd.0005137.g004
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correlated with fibrosis stage and was associated with macrophage phenotype [48]. Patients
with schistosomiasis expressed more Hh ligands (sonic Hh [Shh] and Indian Hh [Ihh]) and
Hh-target genes (Patched and Gli2) than healthy individuals and accumulated more Hh-
responsive myofibroblasts and M2 macrophages, which themselves co-expressed Hh ligands,
sonic Hh, and Indian Hh. These data show that soluble egg antigens (SEA) can directly stimu-
late liver macrophages to produce Hh ligands, which promotes alternative activation of macro-
phages, fibrogenesis, and vascular remodeling in schistosomiasis.
Despite similarities between the roles of Gal-3 and Hh signaling during schistosomiasis-
associated liver fibrosis, it is unclear if (and how) Hh and Gal-3 interact. Interestingly, it has
been demonstrated that Sufu (Suppressor of fused), a negative regulator of the Hh signal trans-
duction pathway, interacts with Gal-3 when this lectin is translocated to the cytoplasm [51].
Both Gal-3 and Hh also exert mitogenic and fibrogenic effects during tumor progression [52].
Future studies, however, will be needed to better understand this crosstalk between HSCs and
immune cells.
The epigenetic landscape in S. mansoni
The epigenetic machinery comprises a series of protein complexes harboring catalytic activities
that ultimately drive conformational changes in DNA. These changes occur through post-
translational modification of histone proteins, such as histone acetylation. The level of acetyla-
tion is tightly controlled by the interplay between two histone-modifying enzymes, the histone
acetyl transferases (HATs) and HDACs. The former are associated with silencing complexes,
which lead to transcriptional repression, and are grouped into three different classes depend-
ing on the subcellular localization and cofactor binding [53].
HDACs control fungal activity, growth, stress responses, and virulence. For these reasons,
HDACs have also been proposed as therapeutic targets in the treatment of parasitic diseases
elicited by Toxoplasma gondii, Plasmodium falciprum, Trypanosoma brucei, and S. mansoni
[54,55,56,57,58]. On the other hand, HDAC inhibitors (HDACi) have been tested in clinical
trials as potential antitumor agents, which induce cell cycle arrest and tumor apoptosis [59,60].
Recently, HDACi (such as vorinostat) increase the susceptibility of uninfected CD4+ T lym-
phocytes to infection with HIV [61] and have been considered novel alternative antifungal
agents [62].
During its life cycle, S. mansoni undergoes drastic changes in phenotype that are associated
with epigenetic modifications, including the effects of hSirt2 inhibitors, recently considered a
new antiparasite target [63]. On this basis, a Schistosome Epigenetics Consortium (targets, reg-
ulation, and new drugs) was launched to study the potential utility of HDACs in the treatment
of adult schistosomiasis and to develop alternate treatments for prazinquantel-resistant Schis-
tosoma. Indeed, findings from several studies support the role for HDAC in the Schistosoma
life cycle. Class I HDACs (1, 3, and 8), for example, are overexpressed in all life cycle stages of
the parasite and present a highly conserved catalytic domain, which resembles human HDACs
[64].
The treatment of the schistosomula and the adult form of the parasite with HDACi in vitro
also increased expression levels of caspases 3/7 (which are effector caspases) and directly corre-
lated with the degree of acetylation on the histone H4 [57]. HDACi also induced apoptosis of
the larvae and adult form via inhibition of the NFκB pathway [56]. These findings indicate
that HDACi may represent a useful alternative modality in the treatment of schistosomula
and/or the adult form.
It has been shown that treatment with HDACi induces an anti-inflammatory cytokine pro-
file and a reduction in the number of classically activated macrophages (i.e., M1 markers) [65].
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As such, it can be envisaged that HDACi may promote a more anti-inflammatory response by
decreasing the host’s immune response to egg antigens. In turn, this dampens the inflamma-
tory reaction, reduces hepatic injury, and abrogates liver fibrogenesis.
HDACs play an important role in macrophage differentiation and polarization [66,67].
During schistosomiasis, chromatin remodeling can be associated with macrophage activation
and response following egg deposition [68,69]. Hence, it is plausible that HDACs (and
HDACi) can be used to shape monocyte–macrophage phenotypes and to indirectly modify
fibrosis outcomes following Schistosoma infection. Despite enthusiasm for the potential use of
HDACi, it is important to consider potential off-target effects in vivo. For instance, HDACs
play a critical role in many other physiological systems, and the potential loss of one function
may lead to long-lasting chronic inflammatory complications.
Possible crosstalk between Gal-3, HDACs, and Hh signaling during
progressive liver fibrosis in S. mansoni-infected mice
The aggregate evidence presented suggests that Gal-3, Hh signaling, and epigenetic factors are
key modulators of Schistosomiasis-associated liver fibrosis. Future research will be necessary
to better understand how these factors (alone or in combination) drive liver fibrosis progres-
sion and to identify how we can target them effectively to enhance fibrosis resolution. The
potential impact of these research areas is extremely relevant to public health in developing
countries. Millions of dollars are spent annually to treat patients with end-stage liver and kid-
ney diseases from S. mansoni, and current therapies are ineffective in reversing liver fibrosis.
Currently, the use of praziquantel shows significant amelioration of hepatic fibrosis and offers
the potential of a new chemotherapy for hepatic fibrosis resulting from schistosomiasis [70].
However, molecular mechanisms involved in this treatment are poorly understood. As early
fibrosis is potentially reversible, we have highlighted promising targets and discussed strategies
needed to translate these to the bedside.
We summarized our opinion in Fig 4. Liver histology of Lgals3+/+ and Lgals3-/- infected
mice reveal that S. mansoni eggs are frequently trapped in the hepatic portal system, where ini-
tial signaling to monocyte recruitment plays a central role in establishing the disease. We
suggested that macrophages are distinctly generated according to monocyte phenotypes mobi-
lized from the bone marrow. During the pregranulomatous phase, monocyte recruitment is
characterized by mixed Ly6Chigh and Ly6Clow cells (Fig 4A). It is plausible to suggest that this
mobilization is imbalanced in the absence of Gal-3, and thus, macrophage differentiation and
myofibroblast activation would be significantly disturbed in the liver of Schistosoma-infected
mice. Consequently, macrophages are not properly activated, suggesting that Shh secretion by
myofibroblast cells would be downregulated.
The chronic phase of schistosomiasis is hallmarked by liver fibrosis, and in the absence of
Gal-3, diffuse collagen fibers could be result of abnormal events on macrophages and HSCs.
Here, we proposed that Shh-activated macrophages in Lgals3+/+ mice express high levels of
Gal-3. It is possible that HDAC induces Gli translocation after deacetylation, as observed in
tumors [71], and upregulates Gal-3 gene expression (Fig 4B). At least in part, Gal-3 is secreted
to extracellular spaces and acts on distinct cell types. These cells are also responsible for M2–
cytokine secretion after IL-4 stimulation [72]. We suggested that both mechanisms could be
attributed to HDAC activity. Recent work from our group has shown an anti-inflammatory
role for HDAC activity inhibitors, leading preferentially to an M2 macrophage phenotype
[67].
Our data showed that activated HSCs obtained from the liver of Lgals3-/- mice showed
reduced mRNA levels of α-SMA and eotaxin, whereas mRNA levels of IL-4 were increased in
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comparison to Lgals3+/+ mice. Then, we hypothesized that the TGF-β1 pathway constitutes
an interesting target for future studies linking Gal-3 and HDACs regulating α-SMA synthesis
(Fig 4B). Moreover, we suggested that Gal-3 and HDACs inhibit eotaxin synthesis dependent
on IL-4 activation (Fig 4B). Finally, it is possible that IL-4 gene expression is regulated by
mechanisms involving Gal-3, considering that data obtained from Lgals3-/- infected mice.
For this reason, it is an opening question regarding the use of these classes of inhibitors as a
therapeutic approach. Indeed, considering that the first step of the infection is under the con-
trol of a macrophage, the outcome of the disease needs to be further investigated, including in
the Lgals3-/- infected mice. The downmodulation of macrophages in Lgals3-/- infected mice
during the first step of the infection could be directly associated with a type of fibrogranuloma-
tous reaction in the liver and, consequently, drive profibrotic events during schistosomiasis.
Perspectives and conclusions
Epigenetic modifiers may be useful in promoting an anti-inflammatory response. Both Gal-3
and the Hh pathway are promising antifibrotic targets. Here, we proposed that cell signaling
pathways involving Gal-3, HDCAs, and Hh mechanisms could be involved with pathogenesis
of schistosomiasis and consequently liver fibrosis. We suggest that these molecular mecha-
nisms should be studied before the establishment of egg deposition, macrophage differentia-
tion in the liver, and collagen deposition, hallmarks of the hepatic failures due to liver fibrosis
in schistosomiasis.
Methods
Schistosomal infection
Inbred C57/bl6 (Lgals3+/+) and Lgals-3-/- mice were obtained from the colony at the Federal
University of Rio de Janeiro (Brazil). Mice 4 weeks of age were infected by transcutaneous pen-
etration of 40 S. mansoni cercariae (BH strain, Oswaldo Cruz Institute, Rio de Janeiro, Brazil).
Mice were killed on day 90 post-infection, corresponding to the chronic phase.
Ethics statement
All procedures with mice were performed in accordance with institutional guidelines (proto-
col number DAHEICB 070, Institute of Biomedical Sciences, Federal University of Rio de
Janeiro).
Histological preparations
For histological analyses, five animals per group were killed under anesthesia given IP (keta-
mine, 35 mg/kg; xylazine, 9 mg/kg, Sigma Chemical Co., St. Louis, Missouri, United States of
America). The liver was removed, cut into 0.5-mm-thick slices, washed in cold saline, and
fixed in Bouin’s fixative. After 6 hours of fixation, specimens were dehydrated in alcohol and
embedded in paraffin. Sections of 5 μm were obtained and stained with hematoxylin and
eosin, Gomori trichrome, and reticulin staining. Bright-field pictures were acquired using an
Evolution MP 5.0 RTV Color camera (Media Cybernetics, Canada).
Isolation and purification of primary murine HSCs derived from
schistosome-infected mice
Mice were killed 90 days after infection. Periovular granulomas were isolated from homoge-
nized liver tissue by sedimentation and digested by collagenase 1A (Sigma-Aldrich, Inc.,
St. Louis, MO, USA). The harvested cells were seeded into 25cm2 tissue culture flask in
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Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% fetal bovine serum. Cells were sub-
cultured by trypsinization that eliminated the trypsin-resistant granuloma macrophages. After
the third passage, homogeneous HSCs derived from hepatic granulomas were obtained. These
cells, named GR-HSCs, were fully described and characterized in previous studies [73].
mRNA extraction and real-time RT-PCR
mRNA was extracted from 0.5 to 1 x 106 cells using TRIzol Reagent following standard proto-
cols. Total RNA was dissolved in water, quantified and stored at -20˚C. cDNA was synthesized
from 1 μg total RNA. RNA was primed with 0.5 μg oligo-(dT) primer, denatured (10 min at
64˚C), and cooled on ice. The following reagents were mixed and added: 10 mM of each deox-
ynucleoside triphosphate (dNTP), 6 μL 5 x reverse transcriptase (RT) buffer, 0.1 mM DTT,
and 200 U of MLV-RT. Reaction was performed by incubation for one hour at 37˚C. During
amplification, we used predesigned TaqMan Gene Expression Assays (Applied Biosystems)
according to the manufacturer’s instructions for IL-5 (NCBI RefSeq: NM_010558.1), eotaxin
(NCBI RefSeq: NM_011330.3), IL-4 (NCBI RefSeq: NM_021283.2), α-SMA (NCBI RefSeq:
NM_007392.3), and HPRT (NCBI RefSeq: NM_013556.2). The qPCR reaction was performed
with a final volume of 25 μL, containing 2 μL of cDNA, 12.5 μL of master mix (Applied Biosys-
tems), and 250 nmol of primers and probe in optical 96-well plates. The fluorescence emission
from each reaction was measured three times during the annealing/extension, and amplifica-
tion plots were analyzed using software from Applied Biosystems. The gene expression data
were normalized using HPRT as a housekeeping gene.
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Key learning points in the review
• Helminthes of the genus Schistosoma cause a neglected tropical disease that affects
approximately 240 million people, mainly in developing countries.
• S. mansoni leads to liver diseases because of egg deposition in the periportal zones,
which induces a granulomatous reaction that culminates in liver fibrosis and portal
hypertension.
• At the beginning of the eggs’ deposition, their antigens elicit a local production of
inflammatory cytokines from resident epithelial cells and macrophages, giving rise to a
macrophage-dependent granulomatous inflammatory reaction.
• The aggregate evidence presented here suggests that Gal-3, Hh signaling, and epige-
netic factors are key modulators of Schistosomiasis-associated liver fibrosis modulated
by macrophages in the beginning of the infection.
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